Kamal Mostafa 4
4 · MAGELLAN HEALTH INC · Filed Nov 12, 2020
Insider Transaction Report
Form 4
Kamal Mostafa
CEO, Magellan Rx Management
Transactions
- Exercise of In-Money
Ordinary Common Stock, $0.01 par value
2020-11-10$66.57/sh+6,000$399,420→ 11,617 total - Sale
Ordinary Common Stock, $0.01 par value
2020-11-10$81.57/sh−6,000$489,420→ 5,617 total - Exercise of In-Money
Stock Option (right to buy)
2020-11-10−6,000→ 34,808 totalExercise: $66.57Exp: 2029-03-05→ Common Stock (6,000 underlying)
Footnotes (3)
- [F1]This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- [F2]Of the 13,603 stock options that vested on March 5, 2020, 7,603 remain available to exercise after the reported transaction. The remainder of 27,205 options shall vest in equal increments on March 3, 2021 and 2022.
- [F3]Not applicable.